ORCHARD PARK, N.Y., June 14 /PRNewswire-FirstCall/ -- MINRAD International, Inc. is set to join the broad-market Russell 3000(R) Index when Russell Investment Group reconstitutes its comprehensive set of U.S. and global equity indexes on June 22, according to a preliminary list of additions posted Friday on http://www.russell.com.
Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(R) Index or small-cap Russell 2000(R) as well as the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
Contact: Timothy Sheehan, VP - Corporate Development tsheehan@minrad.com (716) 855-1068 http://www.minrad.com
About the Company
MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company’s website, http://www.minrad.com.
MINRAD International, Inc.
CONTACT: Timothy Sheehan, VP - Corporate Development of MINRADInternational, Inc., +1-716-855-1068, tsheehan@minrad.com
